10 Stocks to Watch as the Rotation Builds
Mag 7 names are being sold — and that is good news for the rest of the market.
As I Await Microsoft, Alphabet Earnings, Here’s What I’m Not Doing
No one has an edge in guessing how a stock will react to earnings. The edge comes from having a plan for every outcome.
Amazon Leads Unconvincing Bounce After Morgan Stanley Price Target Change
The mega caps did the heavy lifting while most stocks went nowhere.
Odd Biotech Action Is Creating Opportunities for Deal Hunters
Let’s see how the best trades are often found by looking past the indexes and digging into what is going on inside a sector.
Why I’m Not Worried About Those Scary Negative Breadth Studies
The Nasdaq hit a new high while many stocks hit lows. Is it a warning sign? Plus, a favorite gets a boost.
10 Ways I Handle an Ugly Market (Including the Great Sacrifice)
Here’s my strategy for days like this, including how I make a shopping list, buy and take profits.
One of My Top Small-Cap Biotech Picks Made a Move. Here’s How I Trade It
The FDA just granted this biopharma name a key designation. Let me show you in detail how I handle a stock like this.
The Chart Pattern Is Half the Equation. Here’s the Other Half
Identifying chart patterns is easy. Anticipating the catalysts that trigger them is the secret to success.
The Waiting Game: Here Are 12 Stocks I’m Waiting to Add
Just because stocks are lower doesn’t mean they are a good buy.
Meta and Chips Cover Up Market Weakness
Here are a few names I’m watching closely as we work through this difficult period.